Cargando…

Clinical Efficacy of Antianlotinib Combined with Immune Checkpoint Inhibitors in the Treatment of Advanced Non-Small-Cell Lung Cancer and Its Effect on Serum VEGF, CEA, and SCC-Ag

PURPOSE: This study is aimed at investigating the clinical safety and effectiveness of anlotinib combined with immune checkpoint inhibitors (ICIs) in the treatment of non-small-cell lung cancer (NSCLC). METHODS: We selected 68 NSCLC patients treated at the Tumor Hospital Affiliated to Nantong Univer...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Linghui, Chen, Xi, Ding, Lingchi, Zhang, Xuedong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586774/ https://www.ncbi.nlm.nih.gov/pubmed/36276277 http://dx.doi.org/10.1155/2022/1530875

Ejemplares similares

The value of combined detection of CEA, CYFRA21-1, SCC-Ag, and pro-GRP in the differential diagnosis of lung cancer
por: Li, Jiezhou, et al.
Publicado: (2021)

Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA125 and SCC antigens in resectable non-small-cell lung cancer.
por: Díez, M., et al.
Publicado: (1996)

Clinical Efficacy of Osimertinib in Patients with Advanced Non-Small Cell Lung Cancer and Its Effect on Serum CEA and VEGF Expression
por: Wang, Huanyuan, et al.
Publicado: (2022)

Apatinib plus Radiotherapy on the Expression of CEA and VEGF in Advanced Oligometastatic Non-Small-Cell Lung Cancer
por: Zhu, Yanxing, et al.
Publicado: (2023)

Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Zhou, Wenwen, et al.
Publicado: (2021)

Retracted: Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Healthcare Engineering, Journal of
Publicado: (2023)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung
por: Wang, Zizong, et al.
Publicado: (2022)

Tracheal squamous cell carcinoma (SCC) metastatic to the skin in a patient on a checkpoint inhibitor
por: Cassler, Nicole M., et al.
Publicado: (2015)

Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer
por: Chen, Wenjuan, et al.
Publicado: (2022)

Retracted: Effects of Camrelizumab Combined with First-Line Chemotherapy on Serum SCC, VEGF Levels, and Adverse Reactions in Patients with Advanced Squamous Cell Carcinoma of the Lung
por: Intelligence and Neuroscience, Computational
Publicado: (2023)

Recent Advanced in the Treatment of Advanced SCC Tumors
por: Basset-Seguin, Nicole, et al.
Publicado: (2022)

CXCL10 serves as a potential serum biomarker complementing SCC-Ag for diagnosing cervical squamous cell carcinoma
por: Zhang, Jingya, et al.
Publicado: (2022)

The prognostic value of the postoperative serum CEA levels/preoperative serum CEA levels ratio in colorectal cancer patients with high preoperative serum CEA levels
por: Xie, Hai-Lun, et al.
Publicado: (2019)

CEA and CYFRA 21-1 as prognostic biomarker and as a tool for treatment monitoring in advanced NSCLC treated with immune checkpoint inhibitors
por: Dall’Olio, Filippo G., et al.
Publicado: (2020)

Significance of CEA and VEGF as Diagnostic Markers of Colorectal Cancer in Lebanese Patients
por: Dbouk, Hashem A., et al.
Publicado: (2007)

Assessment of the relationship between serum squamous cell carcinoma antigen (SCC-Ag) concentration in patients with locally advanced squamous cell carcinoma of the uterine cervix and the risk of relapse
por: Kubik, Sylwester, et al.
Publicado: (2019)

Pretreatment levels of the serum biomarkers CEA, CYFRA 21–1, SCC and the soluble EGFR and its ligands EGF, TGF-alpha, HB-EGF in the prediction of outcome in erlotinib treated non-small-cell lung cancer patients
por: Romero-Ventosa, Elena Yaiza, et al.
Publicado: (2015)

Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma
por: Cao, Xun, et al.
Publicado: (2012)

Simultaneous Detection of VEGF and CEA by Time-Resolved Chemiluminescence Enzyme-Linked Aptamer Assay
por: Man, Jin, et al.
Publicado: (2020)

The diagnostic value of serum CEA, NSE and MMP-9 for on-small cell lung cancer
por: Xu, Liu, et al.
Publicado: (2016)

The effect of serum CEA on the distribution and clearance of anti-CEA antibody in a pancreatic tumour xenograft model.
por: Pedley, R. B., et al.
Publicado: (1989)

50 years of the physics of the infinitely small at the CEA
Publicado: (1996)

Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
por: Yang, Qixian, et al.
Publicado: (2018)

Relationship of serum CEA levels to tumour size and CEA content in nude mice bearing colonic-tumour xenografts.
por: Lewis, J. C., et al.
Publicado: (1981)

Expression Levels and Clinical Significance of Serum miR-497, CEA, CA24-2, and HBsAg in Patients with Colorectal Cancer
por: Liu, Yan, et al.
Publicado: (2022)

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
por: Zhang, Zhi-Hui, et al.
Publicado: (2015)

Identification of EGFR mutation status in male patients with non-small-cell lung cancer: role of (18)F-FDG PET/CT and serum tumor markers CYFRA21-1 and SCC-Ag
por: Jiang, Maoqing, et al.
Publicado: (2023)

Symbolic Coloured SCC Decomposition
por: Beneš, Nikola, et al.
Publicado: (2021)

CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA
por: Cai, Zerong, et al.
Publicado: (2020)

Role of Serum Vascular Endothelial Growth Factor (VEGF) as a Potential Biomarker of Response to Immune Checkpoint Inhibitor Therapy in Advanced Melanoma: Results of a Pilot Study
por: Khattak, Muhammad A., et al.
Publicado: (2020)

Association between serum biomarkers CEA and LDH and response in advanced non‐small cell lung cancer patients treated with platinum‐based chemotherapy
por: de Jong, Corine, et al.
Publicado: (2020)

Preoperative SCC-Ag and thrombocytosis as predictive markers for pelvic lymphatic metastasis of squamous cervical cancer in early FIGO stage
por: Xu, Fan, et al.
Publicado: (2018)

Advances in immune checkpoint inhibitors therapy for small cell lung cancer
por: Li, Longhui, et al.
Publicado: (2023)

Recombinant canstatin inhibits VEGF‐A‐induced lymphangiogenesis and metastasis in an oral squamous cell carcinoma SCC‐VII animal model
por: Hwang‐Bo, Jeon, et al.
Publicado: (2016)

Diagnosis Value of Combined Detection of Serum SF, CEA and CRP in Non-Small Cell Lung Cancer
por: Zhou, Jing, et al.
Publicado: (2020)

Selenium in serum and neoplastic tissue in breast cancer: correlation with CEA
por: Charalabopoulos, K, et al.
Publicado: (2006)

Serum CEA testing in the post-operative surveillance of colorectal carcinoma.
por: Hine, K. R., et al.
Publicado: (1984)

Serum sialic acid and CEA concentrations in human breast cancer.
por: Hogan-Ryan, A., et al.
Publicado: (1980)

Preoperative serum levels of CEA and CA 242 in colorectal cancer.
por: Carpelan-Holmström, M., et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_3la8v0fbhjhq6vbnm154kp6dib